Pramipexole mitigates rotenone-evoked hepatic injury by regulating inflammatory, antioxidant, apoptosis and NLRP3-mediated pyroptosis
International Immunopharmacology · 2026-10 · 186 · 117106
DOI: 10.1016/j.intimp.2026.117106 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Hebatallah M Saad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of veterinary medicine, Matrouh University, Marsa Matrouh, Egypt. Electronic address: heba.magdy@mau.edu.eg. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Antioxidants, Pramipexole, Anti-Inflammatory Agents. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
The environmental chemical rotenone, which is employed as a natural insecticide, is hazardous to many organs. Thus, this study aimed to elucidate the protective efficacy of an oral administration of pramipexole (PPX) at a dose of 0.5 mg/kg/d against rotenone-induced hepatocellular damage for 60 days. Rotenone administration caused significant hepatic dysfunction, as evidenced by elevated serum AST, ALT, GGT, and bilirubin levels, along with reduced total protein and albumin, indicating impaired liver function. PPX co-administration markedly attenuated these changes, restoring liver enzyme activities and protein levels toward normal values but without a significant effect on albumin level. Additionally, rotenone-induced dyslipidemia was evident through increased total cholesterol, triglycerides, LDL, and VLDL, and decreased HDL levels. PPX significantly improved these lipid disturbances, demonstrating its hypolipidemic potential. Oxidative stress markers revealed that rotenone elevated MDA and GSSG while decreasing SOD and GSH levels. PPX pretreatment notably restored antioxidant balance by reducing lipid peroxidation and enhancing GSH-dependent defenses. At the molecular level, rotenone upregulated pyroptotic (NLRP3, ASC, Caspase-1, GSDMD, IL-18) and inflammatory (TNF-α, IL-1β, MCP-1, MPO) markers while downregulating hepatic miRNA-143-3p expression. PPX co-treatment significantly reversed these alterations, demonstrating anti-inflammatory and anti-pyroptotic efficacy but without any significant effect on miRNA-143-3p. Histopathological and immunohistochemical analyses further confirmed PPX's hepatoprotective role, showing near-normal hepatic structure, reduced necrosis, and suppressed expression of apoptotic (caspase-3, BAX) and macrophage activation (CD68) markers. Overall, PPX pretreatment effectively ameliorated rotenone-induced hepatotoxicity through antioxidant, anti-inflammatory, and anti-apoptotic mechanisms, suggesting its potential therapeutic value in preventing toxin-induced liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Faculty of veterinary medicine, Matrouh University, Marsa Matrouh, Egypt. Electronic address: heba.magdy@mau.edu.eg.
- Department of pharmacology and therapeutics, Faculty of Veterinary medicine, Damanhur University, Damanhur 22511, Egypt. Electronic address: lamiaawasef@vetmed.dmu.edu.eg.
- Department of Veterinary Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, Alexandria University, Egypt. Electronic address: A_elsawasany@alexu.edu.eg.
- Department of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt; Physiology and Biochemistry Department, Faculty of Veterinary Medicine, Ain Shams University, Egypt. Electronic addre…
- Department of Animal Health and Poultry, Animal and Poultry Production Division, Desert Research Center (DRC), Cairo 11753, Egypt. Electronic address: asmaa_vet25@drc.gov.eg.
- The Central Laboratory, Benha University Hospital, Benha University, Benha 13518, Egypt. Electronic address: nihalamer2301@gmail.com.
Zitieren
APA
Saad, H. M., G Wasef, L., Elsawasany, A., Abd El-Maksoud, E. M., Darwish, A. A., Amer, N. E., Salem, E. A., & Elgazzar, A. M. (2026). Pramipexole mitigates rotenone-evoked hepatic injury by regulating inflammatory, antioxidant, apoptosis and NLRP3-mediated pyroptosis. International Immunopharmacology, 186, 117106. https://doi.org/10.1016/j.intimp.2026.117106
Vancouver
Saad HM, G Wasef L, Elsawasany A, Abd El-Maksoud EM, Darwish AA, Amer NE, et al. Pramipexole mitigates rotenone-evoked hepatic injury by regulating inflammatory, antioxidant, apoptosis and NLRP3-mediated pyroptosis. International Immunopharmacology. 2026;186:117106. doi:10.1016/j.intimp.2026.117106
BibTeX
@article{Saad2026,
author = {Saad, Hebatallah M and G Wasef, Lamiaa and Elsawasany, Ahmed and Abd El-Maksoud, Eman M and Darwish, Asmaa A and Amer, Nihal E and Salem, Esraa A and Elgazzar, Ahmed M},
title = {Pramipexole mitigates rotenone-evoked hepatic injury by regulating inflammatory, antioxidant, apoptosis and NLRP3-mediated pyroptosis},
journal = {International Immunopharmacology},
year = {2026},
volume = {186},
pages = {117106},
doi = {10.1016/j.intimp.2026.117106}
}
EUVIMED